HealthEquity Price to Free Cash Flow Ratio 2014-2024 | HQY

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

PE Ratio P/S Ratio Price/Book Ratio Price-FCF Ratio Net Worth

HealthEquity average price to free cash flow ratio for 2024 was 28.92, a 24.43% increase from 2023.
HealthEquity average price to free cash flow ratio for 2023 was 38.27, a 52.47% decline from 2022.
HealthEquity average price to free cash flow ratio for 2022 was 80.52, a 49.75% decline from 2021.

Price to free cash flow ratio can be defined as

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

PE Ratio P/S Ratio Price/Book Ratio Price-FCF Ratio Net Worth

HealthEquity average price to free cash flow ratio for 2024 was 28.92, a 24.43% increase from 2023.
HealthEquity average price to free cash flow ratio for 2023 was 38.27, a 52.47% decline from 2022.
HealthEquity average price to free cash flow ratio for 2022 was 80.52, a 49.75% decline from 2021.

Price to free cash flow ratio can be defined as

Related Stocks
Company Name	Market Cap
Elevance Health (ELV)	$88.4B
Cencora (COR)	$45.7B
Natera (NTRA)	$23.1B
DiDi Global (DIDIY)	$22B
ICON (ICLR)	$18B
Avantor (AVTR)	$14.7B
Viatris (VTRS)	$13.9B
Revvity (RVTY)	$13.9B
BioMerieux (BMXMF)	$12.6B
CochLear (CHEOY)	$12.1B
Solventum (SOLV)	$11.6B
Medpace Holdings (MEDP)	$10.9B
Doximity (DOCS)	$9.7B
EUROFINS SCIENT (ERFSF)	$9.7B
Charles River Laboratories (CRL)	$9.5B
Sonic Healthcare (SKHHY)	$8.2B
Bausch + Lomb (BLCO)	$6.3B
Amplifon S.p.A (AMFPF)	$5.9B
Organon (OGN)	$4.1B
Sotera Health (SHC)	$3.7B
BrightSpring Health Services (BTSG)	$3B
Surgery Partners (SGRY)	$2.6B
Concentras Parent (CON)	$2.5B
GeneDx Holdings (WGS)	$2.5B
Alignment Healthcare (ALHC)	$2.3B
Ardent Health Partners (ARDT)	$2.3B
Premier (PINC)	$2B
PACS (PACS)	$2B
GoodRx Holdings (GDRX)	$1.7B
Teladoc Health (TDOC)	$1.7B